Bladder Cancer in the Elderly: Balancing Disease and Surgical Risk

Program Description

Of all the newly diagnosed bladder cancer patients, 25%-30% of them will have muscle-invasive disease that ideally will require major surgery in the form of a radical cystectomy, bilateral pelvic lymphadenectomy and creation of a urinary diversion as an integral part of curative therapy. Although an invasive extirpative and reconstructive surgery, radical cystectomy is an effective therapy to treat bladder cancer, but it is associated with significant postoperative morbidity and mortality. Recent attention has been paid not only to standardizing, but also fully compiling the true perioperative risk associated with radical cystectomy and urinary diversion.

Intended Audience

This activity has been designed to meet the needs of urologists and supporting clinicians who treat patients with bladder cancer.

Participants can earn 1 credit. The activity expires Nov. 4, 2014. 

Faculty
Daniel J. Canter, MD
Vice Chairman
Urologic Institute of Southeastern Pennsylvania
Department of Urology
Einstein Healthcare Network
Philadelphia, Pennsylvania

    To take this course, go to mycme.com. The log-in information for myCME is the same as McKnight’s. Please note that you will need to complete additional registration information.